2021 Honor Lecture Recipients Chosen by Peers

October 13, 2021 by twilkinson

2021 Honor Lecture Recipients Chosen by Peers

As a result of their efforts to advance work in specific areas of chest medicine, mentorship, training, and furthering the work of CHEST, the following individuals were nominated and selected by their peers to be the 2021 Honor Lecture recipients.

Some recipients of 2021 Honor Lectures share their thoughts on the award, how CHEST has been instrumental to them as an educator, and chest medicine literature from the past year. During CHEST 2021, attend our literature review sessions to hear commentary on and discuss recent literature in chest medicine. Explore the CHEST 2021 session schedule to plan your days.

Ognjen Gajic, MD, FCCP

Ognjen Gajic, MD, FCCP

Roger C. Bone Memorial Lecture in Critical Care

Established in 1997 to honor Roger C. Bone, MD, Master FCCP, a leader in critical care, sepsis, and sepsis research. This lecture honors a world-renowned visionary in pulmonary and critical care medicine who is accomplished as an academician, clinician, and author.

Gajic: I grew up as an intensivist reading Dr. Bone’s papers and have learned so much from him about all aspects of academic critical care medicine: From how to perform meaningful clinical research to a compassionate, humanizing approach to treating critically ill and dying patients.

For me, the generous support from the CHEST Foundation with the Eli Lilly and Company Distinguished Scholar in Critical Care Medicine award was essential for conducting a large international study and the subsequent development of the CERTAIN program (Checklist for Early Recognition and Treatment of Acute Illness and iNjury).

Information overload and misinformation have posed a significant challenge prior to and during the COVID-19 pandemic. The following literature helped provide reliable information and guidance on patient-centered critical care medicine:

  1. Dexamethasone in Hospitalized Patients with Covid-19
  2. Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis: The VICTAS Randomized Clinical Trial
  3. Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry
  4. Checklist for Early Recognition and Treatment of Acute Illness and Injury: An Exploratory Multicenter International Quality-Improvement Study in the ICUs With Variable Resources
  5. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial

Tune in to Dr. Gajic’s lecture, Wednesday, October 20, at 9:15 am CT.


Debra Weese-Mayer, MD

Debra Weese-Mayer, MD

Margaret Pfrommer Endowed Memorial Lecture in Home-based Mechanical Ventilation

This award was established in 1999 by Dr. Eveline Faure and Dr. Allen I. Goldberg and honors their lifelong colleague and friend, Margaret Pfrommer, a polio survivor and patient advocate. This lecture is awarded to a clinician, ventilator-dependent professional, or advocate who has advanced mechanical ventilation and fostered partnerships between physicians and patients.

Weese-Mayer: Having read about the inspirational life and accomplishments of Margaret Pfrommer, receiving this honor lecture means the world to me. My work is focused on children and young adults with rare conditions that require artificial ventilation as life-support, who come from all over the world for evaluation. Margaret’s personal fortitude, incredible inner strength, perseverance, and tenacity led her to a remarkable life of helping others with disabilities. She made a profound impact on the lives of others while facing her own health care needs and ventilator dependence.

Rather than cite specific articles, I’d like to discuss the high quality pediatric- and sleep-focused publications throughout the journal CHEST®. An organization that values intellectual cross-stimulation across specialties and that prizes research focused on the human condition resonates with me. The literature is carefully written, but more importantly, even the most “science-y” papers have a strong connection to the human condition. It’s inspiring to me that CHEST always places the patient first.

Tune in to Dr. Weese-Mayer’s lecture, Monday, October 18, at 3:15 pm CT.


Jean Bourbeau, MD, MS

Jean Bourbeau, MD, MS

Thomas L. Petty, MD, Master FCCP Endowed Memorial Lecture

This award honors Thomas L. Petty, MD, Master FCCP, who trained hundreds of physicians in COPD, oxygen therapy, and spirometry. This lecture is awarded to a CHEST Fellow known for their work in advancing the understanding of COPD pathogenesis and/or treatment and for exceptional mentoring and clinical instruction skills.

Bourbeau: I am honored to receive and have the opportunity to give the Thomas L. Petty, MD, Master FCCP Endowed Memorial Lecture at CHEST 2021. I have always valued Dr. Petty, who is one of the most important physicians in the history of respiratory care, considering that he was responsible for the concept of multidisciplinary respiratory care. Receiving this honor lecture means that when there is teamwork, wonderful things can be achieved. The little changes that I may be responsible for would not have been possible without many people’s collaboration and cooperation.

CHEST has given me the privilege over the years to advance best patient outcomes through innovative chest medicine education. This was only possible because of the contribution of all the people working with me, in particular those at CHEST, CTS (Canadian Thoracic Society), the McGill University Health Centre and its Research Institute, McGill University, and most of all, my patients who have always been an inspiration.

The following literature sticks out to me from the past year:

  1. Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults
  2. Air pollution, lung function and COPD: results from the population-based UK Biobank study
  3. Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality
  4. Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease
  5. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

Tune in to Dr. Bourbeau’s lecture, Wednesday, October 20, at 2:15 pm CT.


Peter Mazzone, MD, MPH, FCCP

Peter Mazzone, MD, MPH, FCCP

Richard S. Irwin, MD, Master FCCP Honor Lecture

This lecture honors Richard S. Irwin, MD, Master FCCP, and his lifelong contributions in pulmonary and critical medicine. This lecture is awarded to a clinician, or health care provider, who has advanced patient-focused care within the chest medicine community.

Mazzone: Getting nominated to deliver this honor lecture helped remind me of the privilege we are given as clinicians. I think when we start our journey in medicine, we begin with the notion that our primary purpose is to help individuals be well. We quickly learn that there isn’t always an absolute right and wrong answer and that a big part of helping individuals is to make sure they understand their options. We help them to make choices consistent with both best practices and their personal values. I remember listening to prior honor lecture presentations and thinking how accomplished the speakers were and how satisfying it must be to have accomplished so much. It is humbling to receive this recognition, particularly given my respect for what Dr. Irwin accomplished through the years, and what he has contributed to CHEST.

CHEST has given me opportunities to be an educator on a national and international stage. It has provided me with a forum to help others practice high quality medicine and thus feel like I am having an impact. My experiences with CHEST have reinforced my perception of the value of clinical education.

I am fortunate to get to read and review many standout articles in my role with the journal. I would encourage you to attend the “Best of CHEST” journal session at this year’s meeting, where four of our most impactful original research submissions will be discussed.

Tune in to Dr. Mazzone’s lecture, Tuesday, October 19, at 8 am CT.